In light of the advancements introduced by iPSC-derived cardiomyocyte modeling, the present review aims to describe the principal pathophysiological mechanisms associated with DMD, with the purpose of defining to what extent these mechanisms are specific to dystrophin depletion or rather, they are part of the wider spectrum of DCM-related cardiac abnormalities. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.